Table 1.
Cohort demographics
| Liver transplants (n = 364) N (%)/Median (IQR) |
||
|---|---|---|
| Age, y | 58 | (51–63) |
| Sex, male | 231 | (63.5%) |
| BMI, kg/m2 | 30 | (25–34) |
| MELD (allocation) | 23 | (21–28) |
| Ethnicity | ||
| White | 327 | (89.8%) |
| African American | 33 | (9.1%) |
| Other | 4 | (1.1%) |
| Etiology | ||
| ETOH | 77 | (21.2%) |
| NASH | 83 | (22.8%) |
| HBV/HCV | 110 | (30.2%) |
| Other | 94 | (25.8%) |
| Dialysis prior to LT | 58 | (15.9%) |
| LT type | ||
| Whole | 331 | (91.2%) |
| SLK | 32 | (8.8%) |
| Donor age, y | 38 | (27–52) |
| Donor BMI, kg/m2 | 28 | (24–32) |
| DCD | 24 | (6.6%) |
| Total ischemia time, min | 352 | (290–445) |
| Biliary complications | 65 | (17.86%) |
| Hepatic artery thrombosis | 10 | (2.7%) |
| Primary nonfunction | 3 | (0.8%) |
| Acute cellular rejection | 12 | (3.3%) |
| Length of stay, d | 8 | (6–16) |
| 30-d readmission | 101 | (37.6%) |
| 30-d mortality | 7 | 1.9% |
| 1-y mortality | 15 | 4.1% |
| Preoperative TEG | ||
| R time, s | 50 | (40–60) |
| k time, s | 120 | (76.3–180) |
| MA, mm | 52.1 | (45–59.1) |
| α angle, ° | 72.7 | (66.4–77.1) |
| Preoperative coagulation status | ||
| Hypocoagulable | 170 | (46.7%) |
| Nonhypocoagulable | 194 | (53.3%) |
DCD, donation after cardiac death; ETOH, alcoholic cirrhosis; HBV, hepatitis B virus; HCV, hepatitis C virus; NASH, nonalcoholic steatohepatitis; SLK, simultaneous liver-kidney.